Search results for: wound care product

Country of Origin designation for all products. Ability to provide an uninterrupted supply of products on a national scale. Technical Literature that clearly shows the product(s) meet the identified salient characteristics (if submitting an or-equal item). Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified.

Page 5 of 7 Page 2 of 7 SPECIAL / AWARD NOTICE Solicitation #: 36C24C19Q0032 Title: Wound Care MSPV Product Category As established within the solicitation, this procurement was set-aside according to the order of priority for contracting preferences as detailed in 38 U.S.C. § 8127 and included a tiered evaluation approach pursuant to VA Procurement Policy Memorandum (PPM) 2018-04.

The product service code is G004, Social Social Rehabilitation. 3. Interested and capable Contractors shall respond to this notice no later than May 13th, 2024 10:00 AM PST by providing the following via email only to benjumar.bayoneta@va.gov.

DO NOT SHIP UNTIL CALLED FOR BY AGENCY. * The Contractor is to assemble individual wound care kits ("kit" or "kits") consisting of the products specified within this RFx. Kit composition given below. The Agency will call for/order kits as needed throughout the contract period.

The ability to produce solid wound dressings (with and without cerium-ions) that are lightweight and easily deployed by medical and nonmedical personnel to treat wounds at or near point of injury.  Dressing should not require special storage requirements.  When placed on the wound, the dressing must be easily removable to allow wound wash with sterile water or saline, and replaced with a fresh dressing. 

KCI Wound VAC for Inpatient Care Brand name or Equal 2,398 Day 3001 OY 3 Daily Wound VAC Lease POP must begin 6/1/2027 to 5/31/2028.

Country of Origin designation for all products. Ability to provide an uninterrupted supply of products on a national scale. Technical Literature that clearly shows the product(s) meet the identified salient characteristics (if submitting an or-equal item). Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified.